Authors: BANZ K THOMAS AM OLIVIERI D

Citation: K. Banz et al., ECONOMIC-EVALUATION OF RIBOSOMAL IMMUNOTHERAPY IN PATIENTS WITH CHRONIC EAR, NOSE AND THROAT AND RESPIRATORY-TRACT INFECTIONS - RESULTS FORITALY, Biodrugs, 10(5), 1998, pp. 385-396

Authors: BANZ K DINKEL R HANEFELD M SCHWANEBECK U

Citation: K. Banz et al., EVALUATION OF THE POTENTIAL CLINICAL AND ECONOMIC-EFFECTS OF BODYWEIGHT STABILIZATION WITH ACARBOSE IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS - A DECISION-ANALYTICAL APPROACH, PharmacoEconomics, 13(4), 1998, pp. 449-459

Authors: SERRUYS PW BANZ K DARCIS T MIGNOT A VANES GA SCHWICKER D

Citation: Pw. Serruys et al., RESULTS OF A METAANALYSIS OF TRAPIDIL, A PDGF INHIBITOR - A SUFFICIENT REASON FOR A 2ND-LOOK TO THE PHARMACOLOGICAL APPROACH TO RESTENOSIS, The Journal of invasive cardiology, 9(8), 1997, pp. 505-512

Authors: BANZ K SCHWICKER D THOMAS AM

Citation: K. Banz et al., ECONOMIC-EVALUATION OF IMMUNOPROPHYLAXIS IN CHILDREN WITH RECURRENT EAR, NOSE AND THROAT INFECTIONS, PharmacoEconomics, 6(5), 1994, pp. 464-477

Authors: BANZ K SCHWICKER D

Citation: K. Banz et D. Schwicker, COST-EFFECTIVENESS OF INTERFERON-ALPHA-2A IN CHRONIC VIRAL-HEPATITIS, Die medizinische Welt, 45(7-8), 1994, pp. 320-326